Skip to main content

Table 1 Descriptive statistics at baseline by treatment group

From: Capsaicinoids supplementation decreases percent body fat and fat mass: adjustment using covariates in a post hoc analysis

 

Capsimax 2 mg

Capsimax 4 mg

Placebo

Baseline variables

 

N

Mean ± SD

N

Mean ± SD

N

Mean ± SD

 Age

27

31.07 ± 12.02

22

28.86 ± 11.58

28

28.71 ± 10.57

 Height

27

170.13 ± 9.49

22

170.17 ± 8.58

28

173.05 ± 11.11

 Weight

27

79.02 ± 20.12

22

80.16 ± 16.80

28

83.51 ± 19.67

 SBP

27

115.04 ± 14.75

22

117.95 ± 10.28

28

118.89 ± 10.02

 DBP

27

70.22 ± 10.18

22

73.18 ± 8.02

28

72.89 ± 9.64

 BMI

27

27.02 ± 5.88

22

27.42 ± 4.15

28

27.80 ± 6.01

 Waist

25

86.84 ± 17.38

22

89.90 ± 12.44

25

94.58 ± 17.87

 Hip

25

102.44 ± 17.35

22

106.83 ± 10.27

25

107.36 ± 12.85

 WHR

25

0.85 ± 0.06

22

0.84 ± 0.08

25

0.88 ± 0.09

Covariates

 Lean Mass

27

50,234.82 ± 14,130.64

22

52,153.33 ± 12,140.28

28

53,581.51 ± 14,316.47

 Fat Mass

27

20,570.47 ± 11,206.61

22

19,903.67 ± 9337.78

28

20,960.33 ± 11,799.70

 Protein Intake

26

82.52 ± 38.95

22

100.32 ± 68.52

27

88.66 ± 39.97

 Carbohydrate Intake

26

239.61 ± 287.44

22

186.27 ± 70.64

27

188.05 ± 80.82

 Fat Intake

26

66.67 ± 24.71

22

76.99 ± 34.58

27

77.75 ± 45.28

 Serum Total-C

27

173.33 ± 27.97

22

168.36 ± 37.87

28

178.93 ± 42.75

  1. Total-C Total cholesterol; BMI Body mass index; SBP Systolic blood pressure; DBP Diastolic Blood Pressure; WHR Waist Hip Ratio
  2. 1) Main Effect Multivariate p (Wilks’ Lambda) = 0.7073 for Baseline Variables. Univariate Main Effect p-values in all instances were p > 0.05 and ranged from p = 0.3047 to p = 0.8695. 2) Main Effect Multivariate p (Wilks’ Lambda) = 0.0.8562 for Baseline Covariates. Univariate Main Effect p-values in all instances were p > 0.05 and ranged from p = 0.3540 to p = 0.9438. 3) Baseline covariates explained extraneous variance and increased statistical power. Covariates did not dramatically change mean outcomes. There were no baseline differences. 3) N Number of subjects